Search results
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 3 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Prediction: These 2 Growth Stocks Could Triple By 2030 | The Motley Fool
The Motley Fool· 1 day agoDoing so requires a compound annual growth rate of 20.1%, well above the broader market's historical...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 3 days agoUSA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden's "Cancer ...
Mirum Pharmaceuticals Inc (MIRM) Q1 2024 Earnings Call Transcript Highlights: Soaring Sales and ...
GuruFocus.com via Yahoo Finance· 4 days agoQ: Can you provide any updates on the potential for orphan drug status for Maralixibat in the EU? A: (Christopher Peetz, CEO) - Discussions...particularly ...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 5 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show...
Digital Journal· 2 days agoORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 3 days agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a Gilead Company (NASDAQ: GILD), and Arcellx,...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
WTNH-TV New Haven· 4 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage ...
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Quad-City Times· 4 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors